COVID-19, Vaccinations, and Blood Cancer Patients: The LLS Registry and Q&A – Module 5

CME: .75

March 3, 2022
/ Print / Reprints /
| Share More
/ Text Size+

Target Audience

This activity is designed to meet the educational needs of hematologists, oncologists, and other healthcare professionals involved in the diagnosis and treatment of patients with blood cancers.

Program Overview

This activity provides a review of data from the Leukemia & Lymphoma Society patient registry on SARS-CoV-2 vaccination in patients with blood cancer and audience Q&A.

Learning Objective

Upon completion of this activity, participants should be better able to:

  • Analyze the impact of COVID-19 and its effect on therapy and outcomes in blood cancer patients

Post a comment to this article